Skip to main contentSkip to search and navigation

UEF eREPOSITORY

    • English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working group on Atherosclerosis and Vascular Biology

Thumbnail
Files
Article (226.6Kb)
Self archived version
final draft
Date
2018
Author(s)
Caporali, A
Bäck, M
Daemen, MJ
Hoefer, IE
Jones, EA
Lutgens, E
Matter, CM
Bochaton-Piallat, ML
Siekmann, AF
Sluimer, JC
Steffens, S
Tuñón, J
Vindis, C
Wentzel, JJ
Ylä-Herttuala, S
Evans, PC
Unique identifier
10.1093/cvr/cvy184
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Caporali, A. Bäck, M. Daemen, MJ. Hoefer, IE. Jones, EA. Lutgens, E. Matter, CM. Bochaton-Piallat, ML. Siekmann, AF. Sluimer, JC. Steffens, S. Tuñón, J. Vindis, C. Wentzel, JJ. Ylä-Herttuala, S. Evans, PC. (2018). Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working group on Atherosclerosis and Vascular Biology.  CARDIOVASCULAR RESEARCH, 114 (11) , 1411-1421. 10.1093/cvr/cvy184.
Rights
© Authors
Licensed under
All rights reserved
Abstract

Modulation of vessel growth holds great promise for treatment of cardiovascular disease. Strategies to promote vascularization can potentially restore function in ischaemic tissues. On the other hand, plaque neovascularization has been shown to associate with vulnerable plaque phenotypes and adverse events. The current lack of clinical success in regulating vascularization illustrates the complexity of the vascularization process, which involves a delicate balance between pro- and antiangiogenic regulators and effectors. This is compounded by limitations in the models used to study vascularization that do not reflect the eventual clinical target population. Nevertheless, there is a large body of evidence that validate the importance of angiogenesis as a therapeutic concept. The overall aim of this Position Paper of the ESC Working Group of Atherosclerosis and Vascular biology is to provide guidance for the next steps to be taken from pre-clinical studies on vascularization toward clinical application. To this end, the current state of knowledge in terms of therapeutic strategies for targeting vascularization in post-ischaemic disease is reviewed and discussed. A consensus statement is provided on how to optimize vascularization studies for the identification of suitable targets, the use of animal models of disease and the analysis of novel delivery methods.

Subjects
post-ischaemic angiogenesis   pre-clinical studies   gene and cell delivery   clinical trials   
URI
https://erepo.uef.fi/handle/123456789/6937
Link to the original item
http://dx.doi.org/10.1093/cvr/cvy184
Publisher
Oxford University Press (OUP)
Collections
  • Terveystieteiden tiedekunta [1324]
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap
Search

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subjectThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subject

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap